Digene HPV test helps identify high-risk women for cervical cancer
- CBI sought part RTI exemption, Govt gave it full
- Screen Awards: Milkha, Ram-Leela and Madras Cafe dominate
- DGCA seeks fresh public objections after clearing AirAsia for take-off
- Delhi: 51-year-old Danish national alleges gangrape, 15 detained for questioning
- I wonder if I will be able to ever reunite with my husband, my kids. I miss them: Devyani
As many as 288 women underwent the digene HPV test which helped identify high-risk women for cervical cancer at an early stage, as part of a study conducted by the Department of Obstetrics and Gynaecology of Shrimati Kashibai Navale Medical College, Pune, and AyuGen Biosciences.
Researchers Dr Pushpalata Naphade and Dr Hemant Damle showed hat testing for HPV infection may significantly reduce the cervical cancer incidences. Every day as many as 200 women die of cervical cancer in India. The cancer affects primarily women in the age group of 30 to 55, said doctors.
Today, the technology allows for the early detection of the virus through a simple test which clearly differentiates between infection and disease and therefore our treatment options are now more focused on the disease, said researchers.
The study identified about 7 per cent HPV positive women, of which 60 per cent were histopathologically confirmed high-grade pre-cancerous lesions. All these women would have progressed to cancer if they would not have been put through digene HPV test.
Manish S Pungliya of AyuGen Biosciences Pvt Ltd said not many women know about this test and the aim is to spread awareness and take preventive steps towards this deadly but preventable cancer.
Dr Naphade said the test helped them identify high-risk women at an early stage. The test can be used in all patients if made affordable. Women above 30 years should get tested for HPV, she added.